Introduction {#Sec1}
============

Oxidative stress occurs when the equilibrium between cellular production of pro-oxidants and anti-oxidant defense mechanisms is disrupted leading to accumulation of reactive oxygen species (ROS), including the superoxide radical O~2~^∙−^, hydrogen peroxide H~2~O~2~, and the highly reactive hydroxyl radical ∙OH^[@CR1]^. Cells respond to ROS by increasing the expression of anti-oxidant genes as well as by activating pathways that control survival and adaptation to oxidative stress^[@CR2]^. An important pathway induced by oxidative stress involves the activation of phosphatidylinositol 3-kinase (PI3K) owing to inactivation of the phosphatase and tensin homolog deleted in chromosome 10 (PTEN) and/or activation of the adaptor P66^Shc[@CR2]--[@CR4]^. Increased PI3K activity leads to the activation of AKT/protein kinase B (PKB), which in principle promotes survival but can also lead to premature senescence or death under conditions of severe oxidative stress^[@CR4],\ [@CR5]^. Downstream of AKT, the mammalian target of rapamycin complex 1 (mTORC1) integrates intracellular and extracellular cues, including growth factors, amino acids, oxygen, energy status and stress, to regulate several major cellular processes such as protein synthesis and autophagy^[@CR6]^. The activity of mTORC1 can be both positively and negatively regulated by oxidative stress depending on ROS levels and time of exposure to this form of stress^[@CR7]^. mTORC1 is negatively regulated by the tuberous sclerosis complex (TSC), which consists of TSC1 (hamartin), TSC2 (tuberin) and Tre2-Bub2-Cdc16-1 domain family member 7 (TBC1D7) and acts as an inhibitory GTPase-activating protein for the small GTPase RAS homolog enriched in brain (RHEB)^[@CR8]--[@CR10]^. Cells impaired for TSC expression or localization to peroxisomes exhibit increased mTORC1 activity under oxidative stress, which is associated with decreased autophagy and increased cell death^[@CR11],\ [@CR12]^.

An immediate response of cells to oxidative stress is the general inhibition of mRNA translation to retain the equilibrium between protein synthesis and clearance, and to maintain homeostasis^[@CR13]^. Among the different translation inhibitory mechanisms, phosphorylation of the α subunit of the eukaryotic translation initiation factor eIF2 at serine 51 (herein referred to as eIF2αP) plays a prominent role^[@CR14]^. eIF2α is phosphorylated by a family of four serine--threonine kinases, namely heme-regulated inhibitor (HRI), protein kinase double-stranded (ds) RNA-dependent (PKR), PKR-like endoplasmic reticulum (ER) resident kinase (PERK), and general control non-repressible-2 (GCN2)^[@CR14],\ [@CR15]^. Each kinase is activated by distinct forms of stress, a process termed the integrated stress response (ISR)^[@CR14],\ [@CR15]^. Increased eIF2αP results in a severe attenuation of de novo protein synthesis but at the same time promotes translation of select mRNAs like those encoding for the activating transcription factors 4 (ATF4) and ATF5 in mammalian cells, which contribute to adaptive homeostasis^[@CR16],\ [@CR17]^.

Increased eIF2αP plays an important role in the regulation of redox homeostasis and adaptation to oxidative stress^[@CR18]--[@CR20]^. Oxidative stress is linked to ER stress given that accumulation of misfolded proteins in the ER leads to generation of ROS, whose deleterious effects are counterbalanced by the induction of the unfolded protein response (UPR)^[@CR1]^. UPR activates the PERK-eIF2αP arm, which via the translational upregulation of ATF4 results in the transcriptional induction of genes encoding anti-oxidant proteins^[@CR18],\ [@CR19],\ [@CR21]^. The anti-oxidant function of eIF2αP further involves the attenuation of general protein synthesis, which decreases client protein load and prevents illegitimate disulfide bond formation in the ER leading to a sufficient amount of reducing equivalents to alleviate cells from oxidative stress^[@CR22]^. Also, attenuation of protein synthesis by increased eIF2αP prevents ATP depletion, stimulation of mitochondrial oxidative phosphorylation and ROS production^[@CR23]^.

Inactivation of either PERK or eIF2αP in mouse or human primary fibroblasts is associated with increased ROS synthesis and premature senescence^[@CR18]--[@CR20]^. On the other hand, immortalized and tumor cells impaired for eIF2αP are tolerant to intrinsic ROS but become highly sensitive to extrinsic oxidative insults^[@CR20]^. Increased eIF2αP promotes cell adaptation to oxidative stress via the translational upregulation of ATF4 and expression of anti-oxidant genes^[@CR18],\ [@CR19]^. Also, increased eIF2αP determines AKT's function under oxidative stress, which can increase tolerance to oxidative stress or promote death under excessive oxidative stress^[@CR4],\ [@CR24],\ [@CR25]^.

We investigated the role of eIF2αP in TSC2-deficient cells, which are impaired for PI3K-AKT signaling and hyper-active for mTORC1. We found that TSC2-deficient mouse and human cells contain increased ROS and are highly sensitive to oxidative insults. This process is associated with the downregulation of the PERK-eIF2αP arm owing to mTORC1 hyper-activation. We also found that decreased eIF2αP elicits pro-oxidant and pro-death effects in TSC2-deficient cells and is associated with an inhibition of tumor initiation in immune deficient mice. Our work shows that eIF2αP is a nodal point of mTORC1 signaling, which can determine the susceptibility of TSC2-deficient cells to oxidative insults and their efficacy in tumor formation in mice maintained on anti-oxidant diet.

Results {#Sec2}
=======

The hypersensitivity of TSC2-deficient cells to oxidative stress is associated with increased mTORC1 activity and decreased eIF2αP {#Sec3}
----------------------------------------------------------------------------------------------------------------------------------

TSC2^−/−^ mouse embryonic fibroblasts (MEFs) as well as TSC2^−/−^ MEFs reconstituted with TSC2 (herein referred to as TSC2-deficient and proficient cells, respectively^[@CR26]^) were tested for their susceptibility to oxidative stress. Treatment with hydrogen peroxide (H~2~O~2~), which is a natural metabolite and mediator of growth factor signaling^[@CR1]^, increased intracellular ROS production and the susceptibility of TSC2-deficient cells to death compared to TSC2-proficient cells (Fig. [1a, b](#Fig1){ref-type="fig"}). Treatment with H~2~O~2~ increased eIF2αP at a higher level in TSC2-proficient than in TSC2-deficient cells (Fig. [1c, d](#Fig1){ref-type="fig"}). Also, TSC2-deficient cells exhibited increased mTORC1 activity compared to proficient cells as indicated by the higher ribosomal S6 kinase (S6K) T389 phosphorylation in the former than latter cells (Fig. [1c, e](#Fig1){ref-type="fig"}). Treatment with H~2~O~2~ further increased S6K T389 phosphorylation in TSC2-deficient cells compared to proficient cells indicating the hyper-activation of mTORC1 in these cells under oxidative stress (Fig. [1c, e](#Fig1){ref-type="fig"}). These data provided a link between mTORC1 and eIF2αP in ROS production and susceptibility of TSC2-deficient cells to oxidative stress.Fig. 1Increased mTORC1 activity and decreased eIF2αP in TSC2-deficient cells under oxidative stress.**a**TSC2-proficient (TSC2^−/−^+TSC2) and TSC2-deficient (TSC2^−/−^) MEFs were treated with 0.1 mM H~2~O~2~ for 45 min followed by the addition of 5 µM DCFDA with for 25 min and detection of ROS levels by FACS analysis. **b** TSC2-proficient and TSC2-deficient MEFs were treated with 2 mM H~2~O~2~ for 8 h. The percentage of cell death was determined by measuring the population of cells in sub-G~1~ by propidium iodide staining and FACS analysis. **a**, **b** Histograms represent the mean of 3 independent experiments and the error bars indicate the SEM. \*\*\**p* \< 0.005. **c** TSC2-proficient or TSC2-deficient MEFs were treated with 0.5 mM H~2~O~2~ for 2 h. Protein extracts (50 µg) were immunoblotted for the indicated proteins. **d**, **e** Quantification of that ratio of eIF2α-pS51/eIF2α and S6K pT389/S6K from three separate experiments with cells and conditions shown in **c**. \**p* \< 0.05 \*\**p* \< 0.01 \*\*\**p* \< 0.005

PERK activity is impaired in TSC2-deficient cells under oxidative stress {#Sec4}
------------------------------------------------------------------------

Considering that an equal amount of H~2~O~2~ resulted in different ROS levels between TSC2-proficient and TSC2-deficient MEFs (Fig. [1a](#Fig1){ref-type="fig"}), we investigated whether the differences in mTORC1 activity and eIF2αP between the two cell types were an effect of variable ROS production. To this end, ROS levels were assessed in these cells subjected to increasing concentrations of H~2~O~2~. The results confirmed that ROS production was higher in TSC2-deficient than proficient MEFs in response to equal amounts of H~2~O~2~ (Fig. [2a](#Fig2){ref-type="fig"}). Colony formation assays showed that the survival of both cell types was inversely proportional to the amount of H~2~O~2~ treatment (Fig. [2b](#Fig2){ref-type="fig"}). Nevertheless, TSC2-proficient MEFs displayed a better survival than TSC2-deficient MEFs in response to treatments with an equal amount of H~2~O~2~ (Fig. [2b](#Fig2){ref-type="fig"}). Treatment with increasing concentrations of H~2~O~2~ resulted in a higher activation of PERK by autophosphorylation at T980 in TSC2-proficient than deficient MEFs (Fig. [3a](#Fig3){ref-type="fig"}). Also, eIF2αP was induced at a higher level in TSC2-proficient than in deficient MEFs in response to increasing concentrations of H~2~O~2~ (Fig. [3a](#Fig3){ref-type="fig"}). Moreover, phosphorylation of S6K T389 by mTORC1 was increased at a higher level in TSC2-deficient than in proficient MEFs whereas AKT S473 phosphorylation was substantially reduced in TSC2-deficient compared to proficient MEFs under the pro-oxidant treatments (Fig. [3a](#Fig3){ref-type="fig"}).Fig. 2Increased ROS production is associated with increased susceptibility of TSC2-deficient cells to death.**a** TSC2-proficient (TSC2^−/−^ + TSC2) and TSC2-deficient (TSC2^−/−^) MEFs were treated with the indicated concentrations of H~2~O~2~ for 45 min followed by the addition of 5 µM DCFDA for an additional 25 min. Detection of ROS levels in cells was assessed by FACS analysis. Histograms represent the mean of 3 independent experiments and the error bars indicate SEM. \**p* \< 0.05 \*\*\**p* \< 0.005. **b** TSC2-proficient and TSC2-deficient MEFs (2 × 10^3^) were treated with the indicated amounts of H~2~O~2~ for 8 h. Media was refreshed every second day for one week. Cells were fixed in formalin and stained with crystal violet (top panel). Cell survival was assessed by extraction in 10% acetic acid and detection of optical density (OD) at 570 nM (bottom panel). Histogram represent the mean of two independent experiments done in quadruplicate and the error bars indicate SEM. \**p* \< 0.05 \*\*\**p* \< 0.005Fig. 3Impaired PERK activity, eIF2αP and ATF4 expression in TSC2-deficient cells under oxidative stress.TSC2-proficient and TSC2-deficient MEFs (**a**) or LAM cells (**b**) were treated with the indicated concentrations of H~2~O~2~ for 2 h. Protein extracts (50 µg) were immunoblotted for the indicated proteins. Blots are representatives of three (**a**) or two (**b**) biological replicates. The ratios of phosphorylated to total proteins for the representative blots are shown. LE long exposure of blots, SE short exposure of blots

The above data indicated an increased susceptibility of TSC2-deficient MEFs compared to proficient MEFs, when both cell types were exposed to equal concentrations of H~2~O~2~. However, when cells were treated with concentrations of H~2~O~2~ that produced equivalent ROS levels (e.g., 0.5 mM for TSC2-proficient and 0.25 mM for TSC2-deficient MEFs), both cell types were similarly tolerant to oxidative stress (Fig. [2b](#Fig2){ref-type="fig"}). Nevertheless, equal ROS levels resulted in reduced PERK activity and decreased eIF2αP in TSC2-deficient compared to proficient MEFs (Fig. [3a](#Fig3){ref-type="fig"}, compare lanes 4 and 8). This data suggested that decreased PERK activity and eIF2αP was not an effect of variable ROS production between the two cell types.

We also examined the signaling effects of oxidative stress in human lymphangioleiomyomatosis (LAM) 621--101 cells that were deficient in TSC2^[@CR27]^. Treatment with H~2~O~2~ was associated with an inhibition of PERK T982 phosphorylation and decreased eIF2αP in TSC2-deficient LAM cells compared to LAM cells reconstituted with human TSC2 (Fig. [3b](#Fig3){ref-type="fig"}). As with MEFs, AKT S473 phosphorylation was substantially lower in TSC2-deficient than proficient LAM cells in either the absence or presence of H~2~O~2~ (Fig. [3b](#Fig3){ref-type="fig"}). TSC2-deficient LAM cells displayed increased levels of PKR protein (Fig. [3b](#Fig3){ref-type="fig"}), an effect that was also evident but to a lesser extent in TSC2-deficient MEFs (Fig. [3a](#Fig3){ref-type="fig"}). Activation of the eIF2α kinase PKR, which has been linked to oxidative stress^[@CR28]^, by autophosphorylation at T446 was increased in TSC2-deficient compared to proficient LAM cells as indicated by immunoblotting with an antibody specific for human PKR (Fig. [3b](#Fig3){ref-type="fig"}). However, exposure to increasing concentrations of H~2~O~2~ did not significantly alter PKR T446 phosphorylation in TSC2-deficient LAM cells as opposed to PERK T982 phosphorylation, which was gradually reduced (Fig. [3b](#Fig3){ref-type="fig"}). These data suggested that decreased eIF2αP is associated with the downregulation of PERK but not PKR in TSC2-deficient cells under oxidative stress.

Reduced PERK activity and eIF2αP in TSC2-deficient cells under oxidative stress depends on mTORC1 {#Sec5}
-------------------------------------------------------------------------------------------------

Next, we determined whether mTORC1 plays a role in the inhibition of PERK and eIF2αP in TSC2-deficient cells under oxidative stress. To this end, cells were impaired for mTORC1 by infection with lentiviruses expressing RAPTOR shRNA. Downregulation of RAPTOR led to decreased S6K T389 phosphorylation in TSC2-proficient and TSC2-deficient MEFs in either the absence or presence of H~2~O~2~ (Fig. [4a,b](#Fig4){ref-type="fig"}). Loss of mTORC1 activity did not significantly affect PERK T980 phosphorylation or eIF2αP in TSC2-proficient MEFs prior or after H~2~O~2~ treatment (Fig. [4a](#Fig4){ref-type="fig"}). Downregulation of RAPTOR resulted in increased PERK T980 phosphorylation and eIF2αP in TSC2-deficient MEFs in the absence of H~2~O~2~ treatment, and it further increased PERK activity and eIF2αP in the same cells treated with H~2~O~2~ (Fig. [4b](#Fig4){ref-type="fig"}, compare lane 1 with 3 and lane 2 with 4). As with TSC2^−/−^ MEFs, PERK T982 phosphorylation and eIF2αP were increased at a higher level in H~2~O~2~-treated TSC2-deficient LAM cells impaired for RAPTOR compared to the same cells containing RAPTOR (Fig. [4c](#Fig4){ref-type="fig"}, compare lane 3 with 4). Downregulation of RAPTOR resulted in decreased PKR T446 phosphorylation in TSC2-deficient LAM cells in either the absence or presence H~2~O~2~ treatment (Fig. [4c](#Fig4){ref-type="fig"}, compare lane 1 with 2 and lane 3 with 4). This data indicated that mTORC1 increases PKR activity, which, however, is not subjected to further regulation by mTORC1 under oxidative stress. Also, RAPTOR downregulation led to a substantial increase in AKT S473 and glycogen synthase kinase 3β (GSK3β) S9 phosphorylation in TSC2-deficient LAM cells, which were further enhanced by H~2~O~2~ treatment (Fig. [4c](#Fig4){ref-type="fig"}, compare lane 1 with 3 and lane 2 with 4). The increased phosphorylation of AKT and GSK3β in TSC2-deficient cells impaired for RAPTOR can be explained by the alleviation of the negative effects of mTORC1 on PI3K-AKT signaling in these cells as previously shown^[@CR29]--[@CR31]^.Fig. 4Hyper-activated mTORC1 mediates the reduction of PERK activity and eIF2αP in TSC2-deficient cells under oxidative stress.TSC2-proficient (**a**, TSC2^−/−^ + TSC2) or TSC2-deficient MEFs (**b**, TSC2^−/−^) were infected with pLKO lentiviruses lacking (−) or containing (+) an shRNA against mouse RAPTOR. **c** TSC2-deficient LAM cells were infected with pLKO lentiviruses lacking (−) or containing shRNA against human RAPTOR. **a**--**c** Cells were left untreated or treated with 0.5 mM H~2~O~2~ for 2 h. Protein extracts (50 μg) were immunoblotted for the indicated proteins. Quantifications of eIF2α-pS51/eIF2α and PERK-pT982/PERK from three biological replicates are shown. \**p* \< 0.05 \*\**p* \< 0.01 \*\*\**p* \< 0.005. LE long exposure of blots, SE short exposure of blots

eIF2αP in TSC2-deficient cells elicits pro-oxidant and pro-death effects in response to oxidative stress {#Sec6}
--------------------------------------------------------------------------------------------------------

To determine the biological effects of eIF2αP in TSC2-deficient as well as proficient cells, we established cells expressing a hemagglutinin (HA)-tagged form of human eIF2α bearing the S51A mutation (HA-eIF2αS51A)^[@CR32]^. Expression of HA-eIF2αS51A inhibited the phosphorylation of endogenous eIF2α in MEFs as well as in LAM cells in the absence or presence of H~2~O~2~ (Fig. [5a, b](#Fig5){ref-type="fig"}). Expression of HA-eIF2αS51A resulted in increased ROS production in TSC2-proficient MEFs and decreased ROS production in TSC2-deficient MEFs in response to H~2~O~2~ treatment (Fig. [5c](#Fig5){ref-type="fig"}). Also, HA-eIF2αS51A expression rendered TSC2-proficient MEFs increasingly susceptible to H~2~O~2~-mediated death as opposed to TSC2-deficient MEFs, which became increasingly resistance to oxidative stress in the presence of HA-eIF2αS51A (Fig. [5d](#Fig5){ref-type="fig"}). These data indicated that further reduction of eIF2αP in TSC2-deficient cells elicits anti-oxidant and pro-survival effects in response to extrinsic oxidative stress. The data supported a pro-oxidant and pro-death role of eIF2αP in TSC2-deficient cells as opposed to TSC2-proficient cells, in which eIF2αP exhibits anti-oxidant and pro-survival effects.Fig. 5eIF2αP displays pro-oxidant and pro-death effects in TSC2-deficient cells.TSC2-proficient (TSC2^−/−^ + TSC2) and TSC2-deficient (TSC2^−/−^) MEFs (**a**) as well as TSC2-proficient and TSC2-deficient LAM cells (**b**) lacking or expressing HA-eIF2αS51A were left untreated or treated with 0.5 mM H~2~O~2~ for 2 h. Protein extracts (50 µg) were subjected to immunoblotting for the indicated proteins. **c** TSC2-proficient or TSC2-deficient MEFs either lacking or expressing HA-eIF2αS51A were treated with 0.1 mM of H~2~O~2~ for 45 min followed by the addition of 5 µM DCFDA for 25 min and detection of ROS by FACS analysis. **d** TSC2-proficient as well as TSC2-deficient MEFs either lacking or expressing HA-eIF2αS51A were treated with 2 mM H~2~O~2~ for 8 h. Cell death was determined by the percentage (%) of cells in sub-G~1~ after propidium iodide (PI) staining and FACS analysis. **c**, **d** Histograms represent the mean of three independent experiments and the error bars indicate SEM. \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.005

eIF2αP in TSC2-deficient cells mediates anti-tumor effects, which are alleviated by an anti-oxidant diet {#Sec7}
--------------------------------------------------------------------------------------------------------

We further assessed the role of eIF2αP in tumor formation of TSC2-deficient cells in mice based on previous work showing that the TSC2-deficient MEFs employed in our study are tumorigenic in immunocompromised mice^[@CR33]^. Transplantation assays in severe combined immunodeficiency (SCID) Beige mice, which were maintained under a regular diet (RD), showed that TSC2-deficient cells developed tumors \~40 days later than TSC2-proficient cells (Fig. [6a, b](#Fig6){ref-type="fig"}; compare graph a with g). The increased tumorigenic potency of TSC2-proficient compared to TSC2-deficient MEFs was previously reported and attributed to better responses of the former cells to growth factors due to functional PI3K-AKT signaling^[@CR33]^. In addition to accelerated tumor initiation, TSC2-proficient tumors exhibited better growth rates than the TSC2-deficient tumors (Fig. [6a, b](#Fig6){ref-type="fig"}; compare graphs a and g). TSC2-proficient tumors with impaired eIF2αP (i.e. HA-eIF2αS51A-expressing cells) exhibited a minor delay in initiation (\~4 days) but a significant reduction in growth rates compared to control TSC2-proficient tumors with intact eIF2αP (Fig. [6a](#Fig6){ref-type="fig"}; compare graphs a and d). On the other hand, TSC2-deficient tumors with impaired eIF2αP displayed accelerated initiation by \~23 days compared to TSC2-deficient control tumors whereas the rates of tumor growth did not significantly differ between the two cell types (Fig. [6b](#Fig6){ref-type="fig"}; compare graphs e and h) (e and g). These data suggested that eIF2αP facilitates the growth of TSC2-proficient tumors but inhibits the initiation of TSC2-deficient tumors in SCID mice.Fig. 6eIF2αP suppresses TSC2-deficient tumor initiation in mice under pro-oxidant conditions.**a**, **b** TSC2-proficient (**a**) or TSC2-deficient MEFs cells (**b**) either lacking (CON) or expressing HA-eIF2αS51A were transplanted in SCID Beige mice, which were kept on regular diet (RD) or an anti-oxidant diet (AOD). Each group consisted of five female 8-week-old SCID Beige mice, and each mouse received two subcutaneous injections of 2 × 10^6^ cells per site. Tumor initiation was monitored by palpation whereas tumor growth was assessed by measurements of the average volume of *n* = 5 × 2 = 10 tumors per group. **c** Tumor sections from mice under regular diet (RD) or the anti-oxidant diet (AOD) injected with TSC2-proficient or deficient MEFs lacking (control; CON) or expressing HA-eIF2αS51A. Tumor sections were used to detect ROS levels by dihydroethidium (DHE) staining whereas cell nuclei were visualized by 4',6-diamidino-2-phenylindole (DAPI) staining. **d** DHE and DAPI staining in C was quantified by the ImageJ software. Histograms represent the average mean fluorescence intensity (MFI) of ROS levels normalized to DAPI measured in 10 images obtained from tumors grown in three separate mice per group. The error bars indicate SEM. \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.005. **e** Model of eIF2αP function in TSC2-deficient cells under oxidative stress. TSC2 deficiency leads to hyper-activation of mTORC1, which under conditions of increased ROS levels results in the inactivation of PERK. PERK inactivation by mTORC1 is most likely indirect and may involve the action of protein phosphatases implicated in mTORC1 signaling (see text). Downregulation of PERK activity and eIF2αP leads to decreased expression of ATF4, which can disarm anti-oxidant responses and contribute to increased susceptibility of TSC2-deficient cells to oxidative insults. The low levels of eIF2αP in TSC2-deficient cells can establish conditions that favor the inhibition of tumor formation in mice, an effect that is significantly alleviated in mice kept on an anti-oxidant diet

We next examined whether inhibition of tumor initiation of TSC2-deficient cells by eIF2αP is affected by pro-oxidant conditions in the tumor microenvironment. To address this matter, TSC2-proficient and TSC2-deficient MEFs transplanted in SCID mice were kept on an anti-oxidant diet (AOD) consisting of N-acetylcysteine in the drinking water and DL-α-tocopheryl acetate (vitamin E) in the food^[@CR34]^. Treatment of mice with AOD did not affect the initiation of TSC2-proficient tumors but had a substantial inhibitory effect on tumor growth (Fig. [6a](#Fig6){ref-type="fig"}; compare graphs a and b). Tumor growth inhibition in mice subjected to AOD could be explained by previous findings supporting a stimulatory effect of oxidative stress on tumor angiogenesis and growth^[@CR35]^. Also, AOD did not affect the initiation of TSC2-proficient tumors with impaired eIF2αP but exhibited a modest stimulatory effect on their growth rate (Fig. [6a](#Fig6){ref-type="fig"}; compare graphs c and d). When mice were transplanted with TSC2-deficient cells, AOD accelerated the initiation of tumors with intact eIF2αP (control) by 12 days but had no effect on the initiation of tumors with impaired eIF2αP (Fig. [6b](#Fig6){ref-type="fig"}, compare graphs g and h as well as graphs e and f, respectively). Also, the difference in tumor initiation between TSC2-deficient MEFs with intact (control) or impaired eIF2αP decreased from 23 days under RD to 10 days under AOD (Fig. [6b](#Fig6){ref-type="fig"}, compare graphs e and g with graphs f and h, respectively). Collectively, the data suggested that a significant fraction (\~50%) of the anti-tumor effects of eIF2αP on TSC2-deficient cells in mice is alleviated by the anti-oxidant diet.

To confirm the anti-oxidant effects of AOD in mice, ROS production was assessed in tumor sections with the dihydroethidium (DHE) fluorescence method^[@CR36]^. TSC2-proficient tumors with impaired eIF2αP from RD-treated mice exhibited increased ROS levels compared to TSC2-proficient tumors with intact eIF2αP consistent with an anti-oxidant function of eIF2αP in these tumors (Fig. [6c, d](#Fig6){ref-type="fig"}). On the other hand, TSC2-deficient tumors with impaired eIF2αP from RD-treated mice displayed decreased ROS levels compared to TSC2-deficient tumors with intact eIF2αP supporting a pro-oxidant function of eIF2αP in these tumors (Fig. [6c, d](#Fig6){ref-type="fig"}). TSC2-proficient tumors with intact eIF2αP from RD-treated mice exhibited decreased ROS levels compared to TSC2-deficient tumors indicating increased ROS production in tumors lacking TSC2 (Fig. [6c, d](#Fig6){ref-type="fig"}). When mice subjected to AOD, ROS levels were substantially reduced in TSC2-proficient as well as deficient tumors (Fig. [6c, d](#Fig6){ref-type="fig"}). Also, AOD treatment had a stronger effect on the inhibition of ROS levels in TSC2-deficient than TSC2-proficient tumors with intact eIF2αP. Moreover, inhibition of ROS synthesis by AOD was more evident in TSC2-proficient than deficient tumors with impaired eIF2αP (i.e., HA-eIF2αS51A-expressing tumors). These data suggested that eIF2αP mediates anti-oxidant effects in TSC2-proficient tumors and pro-oxidant effects in TSC2-deficient tumors.

Discussion {#Sec8}
==========

We found that TSC2-deficient cells are impaired in the activation of PERK and eIF2αP under oxidative stress, a process that is associated with an increased susceptibility of these cells to oxidative insults (see model in Fig. [6e](#Fig6){ref-type="fig"}). We also found that increased mTORC1 activity is responsible for the inhibition of PERK activity in TSC2-deficient cells under oxidative stress. Hyper-activated mTORC1 is unlikely to exert a direct effect on PERK in TSC2-deficient cells because mass spectrometry data did not identify PERK as a substrate of mTOR^[@CR37],\ [@CR38]^. A plausible explanation is that PERK inactivation is mediated by a phosphatase, whose activity is induced by oxidative stress in TSC2-deficient cells. Previous data implicated protein phosphatase (PP) 2A activity in the regulation of mTOR signaling in cells with increased oxidative stress^[@CR7]^. Contrary to PERK, PKR protein levels and activity are increased in TSC2-deficient cells, which, however, could not account for the inhibition of eIF2αP in response to oxidative insults. TSC2-deficient cells exhibit increased signal transducer and activator of transcription (STAT) signaling^[@CR39]^, which can increase PKR levels at the transcriptional level^[@CR40]^.

Apart from PERK, GCN2, and HRI may play a role in the regulation of eIF2αP in TSC2-deficient cells. Specifically, pharmacological inhibition of mTORC1 leads to GCN2 activation and increased eIF2αP in a mechanism dependent on the catalytic subunit of PP6C^[@CR41]^. Interestingly, eIF2αP is impaired in TSC2-deficient MEFs under stress that causes GCN2 activation such as leucine deprivation or treatment with the histidinyl-tRNA synthetase inhibitor histidinol^[@CR41]^. In *Saccharomyces cerevisiae*, TOR inhibits GCN2 activity through TAP42, a regulator of type 2A-related phosphatase^[@CR42]^, whereas in *Schizosaccharomyces pombe*, Tor2, as part of mTORC1, prevents GCN2 activation and eIF2αP in the presence of nitrogen and amino acids^[@CR43]^. Other studies showed that exposure of *S. pombe* to oxidative stress results in the activation of GCN2 and HRI 2, which is one of the two eIF2α kinases in fission yeast related to mammalian HRI^[@CR44],\ [@CR45]^. In mammalian cells, HRI is activated by oxidative stress and plays an important role in the reduction of oxidative stress in mice during iron deficiency^[@CR46]^.

mTORC1 may decrease eIF2αP in TSC2-deficient cells through additional mechanisms based on its ability to phosphorylate the β subunit of eIF2, which promotes eIF2α dephosphorylation by PP1^[@CR47]^. Decreased eIF2αP may act in a feedback loop to increase mTORC1 activity in TSC2-deficient cells based on previous findings showing an inhibitory effect of increased eIF2αP on mTORC1 activity in cells subjected to pro-oxidant treatments^[@CR24]^. Inhibition of mTORC1 by eIF2αP can take place in cells under different forms of stress via increased expression of Sestrin-2 or protein regulated in development and DNA damage response (REDD1), both of which inhibit mTORC1 and are transcriptionally upregulated by ATF4^[@CR48]--[@CR52]^.

Considering the key role of the PERK-eIF2αP-ATF4 axis in anti-oxidant responses^[@CR19],\ [@CR20]^, its downregulation may account for the increased susceptibility of TSC2-deficient cells to pro-oxidant treatments. Also, decreased eIF2αP delays the initiation of tumor formation of TSC2-deficient cells in immune deficient mice, an effect that is significantly alleviated in mice kept on an anti-oxidant diet. These finds provide a potentially important link between the pro-oxidant function of eIF2αP and inhibition of TSC2-deficient tumor formation in mice. Increased ROS production can promote tumor formation but can also render tumors susceptible to further increase of oxidative stress^[@CR53]^. Oxidative stress in tumors can derive from intrinsic as well as extrinsic sources like tumor-associated fibroblasts or macrophages, which synergize in the induction of a pro-oxidant environment^[@CR54]^. What determines death over survival by eIF2αP in TSC2-deficient cells is not clear but the presence of functional TSC may establish a threshold of eIF2αP above which cells display increased tolerance and survival to oxidative stress. In the absence of TSC function, eIF2αP levels below the threshold may render cells increasingly vulnerable to oxidative stress.

Our study addresses the cell-autonomous effects of eIF2αP on TSC2-deficient tumor formation in immune deficient mice. However, eIF2αP may also control TSC2-deficient tumor formation via immune-regulatory pathways. Specifically, eIF2αP in tumors has been linked to the induction of immunogenic cell death (ICD)^[@CR55]^, which requires the activation of immune-mediated anti-tumor responses in the tumor bed in response to certain chemotherapeutic drugs^[@CR56]^. A recent study showed that increased ROS in TSC-proficient tumor cells under hydrostatic pressure activates the PERK-eIF2αP arm and promotes ICD^[@CR57]^. Thus, the effects of PERK and eIF2αP on tumor formation under pro-oxidant conditions may engage both cell-autonomous and immune-regulatory mechanisms. Considering the ability of an anti-oxidant diet to accelerate the formation of TSC2-deficient tumors in mice, implementation of pro-oxidant diets may have the potential to prevent or delay the development of TSC2-deficient cancer. For example, ascorbic acid (vitamin C) can suppress ovarian and colorectal tumors in immune deficient mice through an increase in oxidative stress, when it is administered parenterally and/or at pharmacological doses^[@CR58]--[@CR60]^. Our work raises the interesting hypothesis that vitamin C and possibly other pro-oxidant dietary supplements could be beneficial for the treatment of TSC-deficient tumors.

Materials and methods {#Sec9}
=====================

Cell culture and treatments {#Sec10}
---------------------------

The generation and culture of TSC2-proficient and TSC2-deficient MEFs was previously described^[@CR26]^. The origin of the LAM 621--101 cells was previously described^[@CR27]^. The generation of TSC2-proficient LAM 621--101 cells was performed by infection with pBABE retroviruses containing a FLAG-tagged form of human TSC2 and selection of cells in 200 µg/mL hygromycin (BioShop Canada). The origin and preparation of viruses expressing shRNAs against mouse or human RAPTOR was previously described^[@CR32],\ [@CR61]^. Generation of eIF2αP-deficient TSC2 MEFs and LAM 621--101 cells was described^[@CR32]^. Colony formation assays of cells subjected to oxidative stress were performed as previously described^[@CR20]^.

Protein extraction and immunoblotting {#Sec11}
-------------------------------------

Protein extraction and immunoblot analyses were performed as described previously^[@CR32]^. The phosphorylation of PERK, AKT, S6K, ATF4, GSK3 or eIF2α was tested in parallel by loading equal amounts of protein extracts (50 µg) from the same set of experiments on two identical SDS-10% polyacrylamide gels. After transfer of proteins, the two identical blots were cut into different pieces based on the size of proteins to be tested. One piece of the blot was probed for the phosphorylated protein of interest whereas the corresponding piece of the replica blot for total protein. The antibodies were obtained from Cell Signaling Technology unless otherwise indicated. The antibodies used were as follows: rabbit monoclonal against phosphorylated eIF2α at S51 (Novus Biologicals), mouse monoclonal against eIF2α, mouse monoclonal against PERK, rabbit monoclonal against phosphorylated S6K at T389, rabbit monoclonal against S6K, rabbit monoclonal against RAPTOR, rabbit monoclonal against phosphorylated AKT S473 or AKT, mouse monoclonal against mouse PKR (B-10; Santa Cruz Biotech.), rabbit monoclonal against human PKR phosphorylated at T446 (clone E120; Abcam), mouse monoclonal against human PKR (clone 13B8-F9;^[@CR62]^), mouse monoclonal antibody to actin (ICN Biomedicals Inc.), rabbit polyclonal against ATF4 (Proteintech), rabbit monoclonal against TSC2, rabbit polyclonal against GSK3β S9. The rabbit monoclonal against phosphorylated PERK at T982 was previously described^[@CR32]^. All antibodies were used at a final concentration of 0.1--1 μg/ml. Anti-mouse or anti-rabbit IgG antibodies conjugated to horseradish peroxidase (HRP) (Mandel Scientific) were used as secondary antibodies (1 × 1000 dilution) and proteins were visualized with enhanced chemiluminescence (ECL) (Thermo Scientific). Protein bands were quantified by the ImageJ software in the linear range of exposure.

Xenograft tumor assays {#Sec12}
----------------------

The xenograft tumor assays were performed as described^[@CR20]^. Specifically, 8-week-old SCID Beige female mice (Charles River Inc.) were subjected to bilateral subcutaneous thigh injections with either TSC2-proficient or deficient MEFs. For each set of the experiment 5 mice were used and each mouse received 2 × 10^6^ cells per injected site. Mice were fed on standard chow (\#2918, Envigo) lacking (RD) or supplemented with 500 IU/g of DL-alpha-tocopheryl acetate (vitamin E) (Envigo) and 1 g/L N-acetylcysteine in the drinking water (AOD)^[@CR34]^. Following tumor transplantation, mice were monitored for signs of pain or discomfort three times per week. Tumor initiation was detected by palpation whereas tumor growth was measured by digital calipers, and tumor volume was calculated by the formula: tumor volume (mm^3^) = 1/2 × (length (mm)) × (width (mm))^2^. The animal studies were performed in accordance with the Institutional Animal Care and Use Committee (IACUC) of McGill University and procedures were approved by the Animal Welfare Committee of McGill University (protocol \#5754).

Flow cytometry analysis {#Sec13}
-----------------------

Cell death analysis by flow cytometry was previously described^[@CR32]^. ROS levels were quantified using 2',7'-dichlorodihydrofluorescein diacetate (DCFDA, Molecular Probes) as reported^[@CR24]^. Data were analyzed using the FlowJo software (Tree Star, Inc.).

Detection of ROS in tissue sections {#Sec14}
-----------------------------------

ROS production was evaluated by the fluorescent probe dihydroethidium (DHE; Sigma)^[@CR36]^. Formalin-fixed, paraffin-embedded 5 µm thick tissue sections were de-paraffinised, treated with xylene, rehydrated through a graded alcohol series and rinsed in deionized water. Sections were then incubated with 4 µM of DHE for 30 min in a dark humidified chamber at 37 °C. Visualization of red fluorescence produced by the oxidation of DHE by free radicals was performed on a Zeiss M1 fluorescence microscope and signals were quantified by the ImageJ software.

Statistical analysis {#Sec15}
--------------------

Error bars represent standard error as indicated and significance in differences between arrays of data tested was determined using two-tailed Student T test (Microsoft Excel).
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